Of these, the KPS score has
consistently been shown to be the major determinant of sur-
vival, secondary only to treatment regimen in most studies.
Time from primary tumor diagnosis to development of
brain metastases holds prognostic value as well, particu-
larly for breast and melanoma primaries, with long intervals
being favorable [13, 15].